A phase 1 study of the CXCR4 antagonist plerixafor in combination with high-dose cytarabine and etoposide in children with relapsed or refractory acute leukemias or myelodysplastic syndrome: A Pediatric Oncology Experimental Therapeutics Investigators' Consortium study (POE 10-03).

Details

Language :

English

ISSN :

15455009

Volume :

64

Issue :

8

Database :

Complementary Index

Journal :

Pediatric Blood & Cancer

Publication Type :

Academic Journal

Accession number :

123565533

Full Text :

https://doi.org/10.1002/pbc.26414